ESR1 and breast cancer: In this study, we aimed to expand on the understanding of the ER-activating ESR1 resistance mutations in primary breast cancer and investigate the relationship of preexisting ESR1 mutations to ET resistance across a very large, real-world population-based early breast cancer cohort.